JAMA Cardiology

SEPTEMBER 29, 2024

The EMBARK-HFpEF multicenter, open-label trial examines the effects of cardiac myosin inhibition with mavacamten in patients with heart failure with preserved ejection fraction with a left ventricular ejection fraction of 60% or greater.

Preserved Ejection Fraction 110

Preserved Ejection Fraction Heart Failure 110

HCPLive

SEPTEMBER 29, 2024

A comparison of the PALISADE and BALANCE trials, with commentary from a leading cardiologist, as the community nears a potential approval in FCS.

98

98

Dr. Smith's ECG Blog

SEPTEMBER 29, 2024

A 50 yo was resuscitated from ventricular fibrillation. He had a prehospital ECG recorded after ROSC: What do you think? This certainly looks like an anterior STEMI (proximal LAD occlusion), with STE and hyperacute T-waves (HATW) in V2-V6 and I and aVL. Although one may have all kinds of ischemic findings as a result of cardiac arrest (rather than cause of cardiac arrest), this degree of ST elevation and HATW is all but diagnostic of acute proximal LAD occlusion.

Cardiac Arrest 80

Cardiac Arrest STEMI Ischemia SCAD 80

Heart Sisters

SEPTEMBER 29, 2024

There’s a lot of judgey judging of chronically ill patients going on out there.

Heart Attack 109

Heart Attack Heart attacks Heart Disease 109

American College of Cardiology

SEPTEMBER 29, 2024

Steroidal mineralocorticoid receptor antagonists like finerenone lower mortality in patients with heart failure and reduced ejection fraction (HFrEF), but more data are needed for patients with heart failure and mildly reduced or preserved ejection fraction (HFmrEF/HFpEF). Findings from the recent FINEARTS-HF trial presented during the ESC Congress 2024 and more recently HFSA 2024 are helping to address this need.

Preserved Ejection Fraction 72

Preserved Ejection Fraction Heart Failure Article 72

Cardiovascular Diabetology

SEPTEMBER 29, 2024

The impact of dynamic changes in the degree of atherosclerosis on the development of prediabetes remains unclear. This study aims to investigate the association between cumulative atherogenic index of plasma (.

Atherosclerosis 52

Atherosclerosis Research 52

Med Page Today

SEPTEMBER 29, 2024

(MedPage Today) -- The benefit-risk profile of finerenone (Kerendia) for heart failure and mildly reduced or preserved ejection fraction (HFmrEF, HFpEF) was arguably unchanged with delayed initiation, according to the FINEARTS-HF trial. An analysis.

Preserved Ejection Fraction 52

Preserved Ejection Fraction Heart Failure 52

The American Journal of Cardiology

SEPTEMBER 29, 2024

Publication date: Available online 28 September 2024 Source: The American Journal of Cardiology Author(s): Hayato Tada, Nobuko Kojima, Yasuaki Takeji, Atsushi Nohara, Masa-aki Kawashiri, Masayuki Takamura

Blood Pressure 52

Blood Pressure Hypertension 52

HCPLive

SEPTEMBER 29, 2024

Individuals diagnosed with retinitis pigmentosa experienced an elevated risk of depressive disorder, compared with the general Korean population.

52

52

Circulation

SEPTEMBER 29, 2024

Circulation, Volume 150, Issue 14 , Page 1087-1089, October 1, 2024.

Heart Disease 49

Heart Disease Hypertension Circulation 49

Circulation

SEPTEMBER 29, 2024

Circulation, Volume 150, Issue 14 , Page 1067-1069, October 1, 2024.

Coronary Artery Bypass Graft 49

Coronary Artery Bypass Graft Circulation 49